Shuttle Pharmaceuticals Holdings, Inc.
SHPH
$0.68
$0.023.06%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 92.83% | 65.23% | 142.72% | 82.51% | 71.65% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 54.84% | 51.43% | 103.33% | 61.58% | 30.61% |
| Operating Income | -54.84% | -51.43% | -103.33% | -61.58% | -30.61% |
| Income Before Tax | -28.18% | -16.53% | -68.75% | -42.43% | -38.71% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -28.18% | -16.53% | -68.75% | -42.43% | -38.71% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -28.18% | -16.53% | -68.75% | -42.43% | -38.71% |
| EBIT | -54.84% | -51.43% | -103.33% | -61.58% | -30.61% |
| EBITDA | -51.17% | -51.49% | -103.51% | -61.71% | -30.67% |
| EPS Basic | 86.14% | 80.95% | 33.28% | 15.90% | -5.37% |
| Normalized Basic EPS | 84.58% | 79.40% | 41.92% | 18.23% | -2.22% |
| EPS Diluted | 86.41% | 79.17% | 31.16% | 13.93% | -7.49% |
| Normalized Diluted EPS | 84.58% | 79.40% | 41.92% | 18.23% | -2.22% |
| Average Basic Shares Outstanding | 1,322.72% | 1,056.16% | 457.94% | 148.44% | 53.85% |
| Average Diluted Shares Outstanding | 1,322.72% | 1,056.16% | 457.94% | 148.44% | 53.85% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |